Holderness Investments Company’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $419K | Buy |
11,388
+488
| +4% | +$23.1K | 0.08% | 177 |
|
|
2025
Q4 | $555K | Sell |
10,900
-3,160
| -22% | -$162K | 0.11% | 150 |
|
|
2025
Q3 | $780K | Buy |
14,060
+2,686
| +24% | +$157K | 0.16% | 118 |
|
|
2025
Q2 | $785K | Buy |
11,374
+1,444
| +15% | +$98.2K | 0.17% | 120 |
|
|
2025
Q1 | $690K | Sell |
9,930
-6,909
| -41% | -$571K | 0.16% | 130 |
|
|
2024
Q4 | $1.45M | Sell |
16,839
-417
| -2% | -$45.1K | 0.32% | 74 |
|
|
2024
Q3 | $2.05M | Buy |
17,256
+753
| +5% | +$100K | 0.45% | 58 |
|
|
2024
Q2 | $2.36M | Buy |
16,503
+1,056
| +7% | +$140K | 0.56% | 48 |
|
|
2024
Q1 | $1.98M | Buy |
15,447
+3,187
| +26% | +$379K | 0.48% | 53 |
|
|
2023
Q4 | $1.27M | Sell |
12,260
-10
| -0.1% | -$989 | 0.35% | 74 |
|
|
2023
Q3 | $1.12M | Buy |
12,270
+520
| +4% | +$45.8K | 0.43% | 60 |
|
|
2023
Q2 | $951K | Buy |
11,750
+4,010
| +52% | +$328K | 0.35% | 72 |
|
|
2023
Q1 | $616K | Buy |
7,740
+340
| +5% | +$24.1K | 0.25% | 98 |
|
|
2022
Q4 | $501K | Sell |
7,400
-300
| -4% | -$17.6K | 0.22% | 107 |
|
|
2022
Q3 | $384K | Hold |
7,700
| – | – | 0.17% | 128 |
|
|
2022
Q2 | $429K | Hold |
7,700
| – | – | 0.18% | 123 |
|
|
2022
Q1 | $428K | Sell |
7,700
-1,600
| -17% | -$82.1K | 0.14% | 147 |
|
|
2021
Q4 | $521K | Sell |
9,300
-100
| -1% | -$5.42K | 0.15% | 140 |
|
|
2021
Q3 | $451K | Buy |
9,400
+100
| +1% | +$4.83K | 0.15% | 139 |
|
|
2021
Q2 | $390K | Buy |
9,300
+400
| +4% | +$15.5K | 0.13% | 153 |
|
|
2021
Q1 | $300K | Buy |
8,900
+100
| +1% | +$3.56K | 0.11% | 166 |
|
|
2020
Q4 | $307K | Hold |
8,800
| – | – | 0.12% | 150 |
|
|
2020
Q3 | $305K | Hold |
8,800
| – | – | 0.13% | 140 |
|
|
2020
Q2 | $288K | Hold |
8,800
| – | – | 0.13% | 141 |
|
|
2020
Q1 | $265K | Buy |
8,800
+300
| +4% | +$8.93K | 0.15% | 133 |
|
|
2019
Q4 | $246K | Hold |
8,500
| – | – | 0.11% | 167 |
|
|
2019
Q3 | $220K | Sell |
8,500
-2,200
| -21% | -$55.6K | 0.1% | 170 |
|
|
2019
Q2 | $273K | Hold |
10,700
| – | – | 0.12% | 156 |
|
|
2019
Q1 | $280K | Hold |
10,700
| – | – | 0.13% | 149 |
|
|
2018
Q4 | $246K | Hold |
10,700
| – | – | 0.13% | 155 |
|
|
2018
Q3 | $252K | Hold |
10,700
| – | – | 0.11% | 173 |
|
|
2018
Q2 | $247K | Hold |
10,700
| – | – | 0.12% | 166 |
|
|
2018
Q1 | $263K | Hold |
10,700
| – | – | 0.13% | 165 |
|
|
2017
Q4 | $287K | Hold |
10,700
| – | – | 0.14% | 157 |
|
|
2017
Q3 | $258K | Hold |
10,700
| – | – | 0.13% | 166 |
|
|
2017
Q2 | $229K | Buy |
+10,700
| New | +$216K | 0.12% | 181 |
|
Other funds holding NVO
DAM
F
Holderness Investments Company's NVO Position: Q1 2026 in Review
Holderness Investments Company increased its Novo Nordisk (NVO) stake by 4.5% in Q1 2026, buying an estimated $23.1K and bringing the position to 11,388 shares worth $419K. The position accounts for 0.08% of the portfolio, ranked #177.
Holderness Investments Company first reported a position in NVO in Q2 2017 and has held it in 36 quarters since. The position peaked at $2.36M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Holderness Investments Company held 11,388 shares of Novo Nordisk worth $419K as of Q1 2026.
- Holderness Investments Company bought 488 Novo Nordisk shares in Q1 2026, an estimated $23.1K.
- Novo Nordisk made up 0.08% of Holderness Investments Company's portfolio in Q1 2026, its #177 holding.
- Holderness Investments Company first reported a position in Novo Nordisk in Q2 2017 and has held it in 36 quarters since.
- Holderness Investments Company's Novo Nordisk position peaked at $2.36M in Q2 2024.
- 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Holderness Investments Company's 13F filing for Q1 2026, filed 12 May 2026.